Cargando…
Clinical profile and clinical risk scores in COVID-19 positive ST-elevation myocardial infarction (STEMI) patients
Autores principales: | Peesapati, Nrushen, Rao, M Srinivasa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier, a division of RELX India, Pvt. Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629311/ http://dx.doi.org/10.1016/j.ihj.2021.11.127 |
Ejemplares similares
-
Lysophospholipids as Predictive Markers of ST-Elevation Myocardial Infarction (STEMI) and Non-ST-Elevation Myocardial Infarction (NSTEMI)
por: Chorell, Elin, et al.
Publicado: (2020) -
Clinical Features of the Aslanger Pattern to Compensate for the Limitation of ST-Elevation Myocardial Infarction (STEMI) Criteria
por: Miyauchi, Eiji, et al.
Publicado: (2023) -
ST-Elevation Myocardial Infarction (STEMI) in a Patient with Moyamoya Disease
por: Livesay, James, et al.
Publicado: (2019) -
Determinants of Exercise Capacity Following ST-Elevation Myocardial Infarction (STEMI)
por: Klimis, Harry, et al.
Publicado: (2021) -
COVID-19 Pneumonia: ST-segment Elevation Myocardial Infarction (STEMI) and Myocarditis
por: Ali, Azhar, et al.
Publicado: (2020)